DAM, which depend on the triggering receptor expressed on myeloid cells 2 (TREM2), are observed in aging, AD, frontotemporal dementia, and amyotrophic lateral sclerosis (ALS). The gene discussed is TREM2; the disease is amyotrophic lateral sclerosis.